EUS Procedures Using RIVOS™ EUS Access Device
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is a prospective study of patients undergoing EUS procedures using the RIVOS™ EUS access device.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat i powyżej
- •Pacjenci poddawani procedurom EUS z użyciem urządzenia dostępu RIVOS™
✗ Disqualifies
- •Wiek poniżej 18 lat
- •Pacjenci nie poddawani procedurom EUS z użyciem urządzenia dostępu RIVOS™
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 10, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Orlando Health Digestive Health Institute
Orlando, United States
Trial contact
Ji Young Bang, MD MPH
Barbara J Broome
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/11/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.